Clinical trials
Phase 3 Bone Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| BioMarin Pharmaceutical | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 1 |
| Mesoblast, Ltd. | 1 |
| Oregon Health and Science University | 1 |
| QED Therapeutics, a BridgeBio company | 1 |
| RenJi Hospital | 1 |
| University of Cincinnati | 1 |
| University of Erlangen-Nürnberg Medical School | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Diseases | 17 |
| Musculoskeletal Diseases | 9 |
| Osteoporosis | 5 |
| Dwarfism | 4 |
| Genetic Diseases, Inborn | 4 |
| Osteochondrodysplasias | 4 |
| Achondroplasia | 3 |
| Bone Diseases, Developmental | 3 |
| Bone Diseases, Metabolic | 3 |
| Bone Neoplasms | 3 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.